Endometrial cancer pathophysiology: Difference between revisions
No edit summary |
No edit summary |
||
| Line 15: | Line 15: | ||
[[Category:Gynecology]] | [[Category:Gynecology]] | ||
[[Category:Oncology]] | [[Category:Oncology]] | ||
[[Category:Grammar]] | |||
{{WikiDoc Help Menu}} | {{WikiDoc Help Menu}} | ||
{{WikiDoc Sources}} | {{WikiDoc Sources}} | ||
Revision as of 03:14, 23 September 2012
|
Endometrial cancer Microchapters |
|
Diagnosis |
|---|
|
Treatment |
|
Case Studies |
|
Endometrial cancer pathophysiology On the Web |
|
American Roentgen Ray Society Images of Endometrial cancer pathophysiology |
|
Risk calculators and risk factors for Endometrial cancer pathophysiology |
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]
Overview
Pathophysiology
.jpg)
Microscopic pathology
The histopathology of endometrial cancers is highly diverse. The most common finding is a well-differentiated endometrioid adenocarcinoma, which is composed of numerous, small, crowded glands with varying degrees of nuclear atypia, mitotic activity, and stratification. This often appears on a background of endometrial hyperplasia. Frank adenocarcinoma may be distinguished from atypical hyperplasia by the finding of clear stromal invasion, or "back-to-back" glands which represent nondestructive replacement of the endometrial stroma by the cancer. With progression of the disease, the myometrium is infiltrated.[1]. There is a squamous component on histology. This component can either be benign (called adenocanthoma) or could be malignant (adenosquamous). It is important to find out the grade of adeno component in the histology section as it does affect prognosis. Secretory variety have best prognosis but is least common. Papillary serous and clear cell varieties are also less common with poorer prognosis.
References
- ↑ Richard Cote, Saul Suster, Lawrence Weiss, Noel Weidner (Editor). Modern Surgical Pathology (2 Volume Set). London: W B Saunders. ISBN 0-7216-7253-1.